An article in conservative magazine Figyelo smears researchers studying immigration, gay rights and gender, in escalating conflict between government and Hungarian Academy of Sciences
The Commission turned to expert foresight analysis to help it design its next big research programme for the 2020s. Nikos Kastrinos, who led the study, describes how it worked
Vytenis Andriukaitis calls ‘fake news’ on Trump drug price blame game. Tariffs on medicines – if ever proposed by the US – would be ‘a humanitarian tragedy’, he says
After ten long years, the European economy has recovered from the crash. Now it is time to power ahead by boosting investment, says Werner Hoyer at a Science|Business conference
An app developed by Google’s AI company saves nurses two hours a day. But so far it is free to use. An independent panel says DeepMind must clarify the business model, a stark illustration that as healthcare AI goes mainstream, the matter of who does what with patient data is coming into sharper focus
It is crucial to incorporate patient perspectives on healthcare innovation and decision making to increase the sustainability of Europe’s healthcare systems. A panel held at the Science|Business annual conference looked at the role Horizon Europe can play in achieving this
Funding science and providing incentives to spur innovation in antibiotics is crucial, but political support for stewardship and prevention of inappropriate use is just as important in ensuring availability of effective and affordable drugs that are used in a responsible way
Chronic skin conditions such as Actinic Keratosis, psoriasis and acne can now be treated in a single appointment, thanks to a new wearable laser that blasts the skin with light.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.